Stocks and Investing Stocks and Investing
Fri, February 24, 2023

Eric Joseph Downgraded (CCCC) to Sell and Decreased Target to $5 on, Feb 24th, 2023


Published on 2024-10-28 01:52:53 - WOPRAI, Eric Joseph
  Print publication without navigation


Eric Joseph of JP Morgan, Downgraded "C4 Therapeutics, Inc." (CCCC) to Sell and Decreased Target from $15 to $5 on, Feb 24th, 2023.

Eric has made no other calls on CCCC in the last 4 months.



There is 1 other peer that has a rating on CCCC. Out of the 1 peers that are also analyzing CCCC, all agrees with Eric's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Derek Archila of "Wells Fargo" Maintained at Hold with Decreased Target to $9 on, Tuesday, January 3rd, 2023
Contributing Sources